Potentially Inadequate Medications in the Elderly: PRISCUS 2.0

The term potentially inadequate medication (PIM) is used to describe substances that may be unsuitable for use inthe elderly and should be avoided. The PRISCUS list, published in 2010, was the first catalog of PIM designed for the Germandrug market to become adopted in practice. While 24% of German...

Celý popis

Uložené v:
Podrobná bibliografia
Vydané v:Deutsches Ärzteblatt international Ročník 120; číslo 1-2; s. 3
Hlavní autori: Mann, Nina-Kristin, Mathes, Tim, Sönnichsen, Andreas, Pieper, Dawid, Klager, Elisabeth, Moussa, Mahmoud, Thürmann, Petra A
Médium: Journal Article
Jazyk:English
Vydavateľské údaje: 09.01.2023
ISSN:1866-0452, 1866-0452
On-line prístup:Zistit podrobnosti o prístupe
Tagy: Pridať tag
Žiadne tagy, Buďte prvý, kto otaguje tento záznam!
Abstract The term potentially inadequate medication (PIM) is used to describe substances that may be unsuitable for use inthe elderly and should be avoided. The PRISCUS list, published in 2010, was the first catalog of PIM designed for the Germandrug market to become adopted in practice. While 24% of German patients aged ≥ 65 years were prescribed at least one PIMper year in 2009, the proportion in 2019 was only 14.5%.BACKGROUNDThe term potentially inadequate medication (PIM) is used to describe substances that may be unsuitable for use inthe elderly and should be avoided. The PRISCUS list, published in 2010, was the first catalog of PIM designed for the Germandrug market to become adopted in practice. While 24% of German patients aged ≥ 65 years were prescribed at least one PIMper year in 2009, the proportion in 2019 was only 14.5%.In a three-round Delphi process, experts from clinical practice and research evaluated whether selected substancesare PIM for the elderly. The participants were provided with dedicated literature including systematic reviews carried out for theparticular purposes of this project.METHODSIn a three-round Delphi process, experts from clinical practice and research evaluated whether selected substancesare PIM for the elderly. The participants were provided with dedicated literature including systematic reviews carried out for theparticular purposes of this project.Fifty-nine persons took part in the Delphi process and, in addition, contributed comments and therapeutic alternatives.Altogether, 187 substances were classed as PIM. One hundred thirty-three of the substances now listed were not in the originalPRISCUS list: these include some oral antidiabetics, all of the selective COX-2 inhibitors, and moderately long acting benzodiazepinessuch as oxazepam. For some other substances, e.g., proton pump inhibitors (PPI), the advisability of treatment formore than 8 weeks was considered as potentially inappropriate, as was the use of ibuprofen in doses >1200 mg/day and formore than 1 week without PPI. Risperidone for more than 6 weeks is also PIM.RESULTSFifty-nine persons took part in the Delphi process and, in addition, contributed comments and therapeutic alternatives.Altogether, 187 substances were classed as PIM. One hundred thirty-three of the substances now listed were not in the originalPRISCUS list: these include some oral antidiabetics, all of the selective COX-2 inhibitors, and moderately long acting benzodiazepinessuch as oxazepam. For some other substances, e.g., proton pump inhibitors (PPI), the advisability of treatment formore than 8 weeks was considered as potentially inappropriate, as was the use of ibuprofen in doses >1200 mg/day and formore than 1 week without PPI. Risperidone for more than 6 weeks is also PIM.The new, greatly extended PRISCUS list must now be validated in epidemiological and prospective studies and itspracticability in routine daily use must be verified.CONCLUSIONThe new, greatly extended PRISCUS list must now be validated in epidemiological and prospective studies and itspracticability in routine daily use must be verified.
AbstractList The term potentially inadequate medication (PIM) is used to describe substances that may be unsuitable for use inthe elderly and should be avoided. The PRISCUS list, published in 2010, was the first catalog of PIM designed for the Germandrug market to become adopted in practice. While 24% of German patients aged ≥ 65 years were prescribed at least one PIMper year in 2009, the proportion in 2019 was only 14.5%.BACKGROUNDThe term potentially inadequate medication (PIM) is used to describe substances that may be unsuitable for use inthe elderly and should be avoided. The PRISCUS list, published in 2010, was the first catalog of PIM designed for the Germandrug market to become adopted in practice. While 24% of German patients aged ≥ 65 years were prescribed at least one PIMper year in 2009, the proportion in 2019 was only 14.5%.In a three-round Delphi process, experts from clinical practice and research evaluated whether selected substancesare PIM for the elderly. The participants were provided with dedicated literature including systematic reviews carried out for theparticular purposes of this project.METHODSIn a three-round Delphi process, experts from clinical practice and research evaluated whether selected substancesare PIM for the elderly. The participants were provided with dedicated literature including systematic reviews carried out for theparticular purposes of this project.Fifty-nine persons took part in the Delphi process and, in addition, contributed comments and therapeutic alternatives.Altogether, 187 substances were classed as PIM. One hundred thirty-three of the substances now listed were not in the originalPRISCUS list: these include some oral antidiabetics, all of the selective COX-2 inhibitors, and moderately long acting benzodiazepinessuch as oxazepam. For some other substances, e.g., proton pump inhibitors (PPI), the advisability of treatment formore than 8 weeks was considered as potentially inappropriate, as was the use of ibuprofen in doses >1200 mg/day and formore than 1 week without PPI. Risperidone for more than 6 weeks is also PIM.RESULTSFifty-nine persons took part in the Delphi process and, in addition, contributed comments and therapeutic alternatives.Altogether, 187 substances were classed as PIM. One hundred thirty-three of the substances now listed were not in the originalPRISCUS list: these include some oral antidiabetics, all of the selective COX-2 inhibitors, and moderately long acting benzodiazepinessuch as oxazepam. For some other substances, e.g., proton pump inhibitors (PPI), the advisability of treatment formore than 8 weeks was considered as potentially inappropriate, as was the use of ibuprofen in doses >1200 mg/day and formore than 1 week without PPI. Risperidone for more than 6 weeks is also PIM.The new, greatly extended PRISCUS list must now be validated in epidemiological and prospective studies and itspracticability in routine daily use must be verified.CONCLUSIONThe new, greatly extended PRISCUS list must now be validated in epidemiological and prospective studies and itspracticability in routine daily use must be verified.
Author Sönnichsen, Andreas
Thürmann, Petra A
Mathes, Tim
Klager, Elisabeth
Moussa, Mahmoud
Mann, Nina-Kristin
Pieper, Dawid
Author_xml – sequence: 1
  givenname: Nina-Kristin
  surname: Mann
  fullname: Mann, Nina-Kristin
– sequence: 2
  givenname: Tim
  surname: Mathes
  fullname: Mathes, Tim
– sequence: 3
  givenname: Andreas
  surname: Sönnichsen
  fullname: Sönnichsen, Andreas
– sequence: 4
  givenname: Dawid
  surname: Pieper
  fullname: Pieper, Dawid
– sequence: 5
  givenname: Elisabeth
  surname: Klager
  fullname: Klager, Elisabeth
– sequence: 6
  givenname: Mahmoud
  surname: Moussa
  fullname: Moussa, Mahmoud
– sequence: 7
  givenname: Petra A
  surname: Thürmann
  fullname: Thürmann, Petra A
BookMark eNpNjbFOwzAUAC1UJNrCDzB5ZEmxn2PHYUBCUYFIRVSUzpVjv4gg12ljZyhfDxIMTHfT3YxMQh-QkGvOFgKEvjXDV8LGL_bAABZMFMUZmXKtVMZyCZN_fkFmMX4ypngJYkru133CkDrj_YnWwTg8jiYhfUHXWZO6PkTaBZo-kC69w8Gf7uj6rd5U2w39GV2S89b4iFd_nJPt4_K9es5Wr0919bDKDlzrlAFarV0uSkQ0bSGl1CU4UzIGyKVTorGALUjImRZOO1Za1zYgDbcSmhZgTm5-u4ehP44Y027fRYvem4D9GHdQSKGU5oLBNwZUTxc
ContentType Journal Article
DBID 7X8
DOI 10.3238/arztebl.m2022.0377
DatabaseName MEDLINE - Academic
DatabaseTitle MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
Database_xml – sequence: 1
  dbid: 7X8
  name: MEDLINE - Academic
  url: https://search.proquest.com/medline
  sourceTypes: Aggregation Database
DeliveryMethod no_fulltext_linktorsrc
Discipline Medicine
EISSN 1866-0452
GroupedDBID 04C
2WC
36B
53G
7X8
AAFWJ
AAWTL
ABIVO
ADBBV
ADOJX
ADZJE
AENEX
ALMA_UNASSIGNED_HOLDINGS
BAWUL
BMSDO
DARCH
DIK
E3Z
EBD
EBS
ECT
EIHBH
ESI
HYE
OK1
RPM
ID FETCH-LOGICAL-p188t-2ec88d439eeeaf7555892da9002e15d63bc2ef2524083d8d09cdfb25a1c52bf22
IEDL.DBID 7X8
ISICitedReferencesCount 61
ISICitedReferencesURI http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000994435100002&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN 1866-0452
IngestDate Thu Jul 10 23:36:58 EDT 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1-2
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-p188t-2ec88d439eeeaf7555892da9002e15d63bc2ef2524083d8d09cdfb25a1c52bf22
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
PQID 2753668130
PQPubID 23479
ParticipantIDs proquest_miscellaneous_2753668130
PublicationCentury 2000
PublicationDate 20230109
PublicationDateYYYYMMDD 2023-01-09
PublicationDate_xml – month: 01
  year: 2023
  text: 20230109
  day: 09
PublicationDecade 2020
PublicationTitle Deutsches Ärzteblatt international
PublicationYear 2023
SSID ssj0061923
Score 2.5427244
Snippet The term potentially inadequate medication (PIM) is used to describe substances that may be unsuitable for use inthe elderly and should be avoided. The PRISCUS...
SourceID proquest
SourceType Aggregation Database
StartPage 3
Title Potentially Inadequate Medications in the Elderly: PRISCUS 2.0
URI https://www.proquest.com/docview/2753668130
Volume 120
WOSCitedRecordID wos000994435100002&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText
inHoldings 1
isFullTextHit
isPrint
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1LS8NAEF7UinjxLb5ZwWva7G4eGw-KFIsFLcVa6K3sEwox6SMV6q93Nk314EXwHsKymXzzzXyz-yF0I2OZEBWHnmFA34JIWo9TCWBoId9rEfiWlAeFn-NOhw8GSbdquM2qscoVJpZArXPleuQNCrw6ijhA7v144jnXKKeuVhYa66jGCONupCsefKsIZW3gCi4eQdUchHR5aIZBlmqI6WdhZFp_h-Kf1n0Wx7_AuMwwrd3_rm0P7VTcEj8sg2EfrZnsAG29VOr5Ibrr5oUbDhJpusDtTGgzmQPVxEuxpgxAPMowUEL86My708Ut7r62e81-D8Pqj1C_9fjWfPIq_wRvTDgvPGoU5xoYhzFG2Njd7JVQLRIAQUNCHTGpqLE0dLecMc21nyhtJQ0FUSGVltJjtJHlmTlBmGpfE6WAXRgRECKE4UJIpogMDLyCnaLr1c4MIT6d6CAyk89nw5-9OfvDM-do2_m5lz2O5ALVLPyD5hJtqo9iNJtelZ_3C6I_rt4
linkProvider ProQuest
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Potentially+Inadequate+Medications+in+the+Elderly%3A+PRISCUS+2.0&rft.jtitle=Deutsches+%C3%84rzteblatt+international&rft.au=Mann%2C+Nina-Kristin&rft.au=Mathes%2C+Tim&rft.au=S%C3%B6nnichsen%2C+Andreas&rft.au=Pieper%2C+Dawid&rft.date=2023-01-09&rft.issn=1866-0452&rft.eissn=1866-0452&rft.volume=120&rft.issue=1-2&rft.spage=3&rft_id=info:doi/10.3238%2Farztebl.m2022.0377&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1866-0452&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1866-0452&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1866-0452&client=summon